CAC2 Antibody

Shipped with Ice Packs
In Stock

Description

Definition and Target

CAC2 Antibody is a polyclonal antibody developed against the biotin carboxylase subunit of heteromeric acetyl-coenzyme A carboxylase (ACCase) in Arabidopsis thaliana. ACCase catalyzes the ATP-dependent carboxylation of acetyl-CoA to malonyl-CoA, a critical step in fatty acid biosynthesis .

Key Features:

  • Target Protein: Biotin carboxylase subunit (encoded by the CAC2 gene) .

  • Molecular Weight: Recognizes a 51 kDa polypeptide in Arabidopsis extracts .

  • Specificity: Reacts exclusively with the CAC2 subunit; preabsorption with the immunizing antigen abolishes reactivity .

  • Functional Inhibition: Inhibits ACCase enzymatic activity in vitro, confirming its specificity .

Role in Fatty Acid Synthesis

CAC2 is essential for fatty acid biosynthesis in plants. The antibody has been used to:

  • Study light-/dark-regulated ACCase activity in chloroplasts .

  • Investigate tissue-specific expression patterns, with highest activity in organs synthesizing membrane lipids or oils (e.g., seeds, flowers) .

Gene Expression Coordination

  • CAC2 expression mirrors that of CAC1 (encoding the biotin carboxyl carrier subunit), suggesting transcriptional coordination .

  • Promoter analysis reveals shared regulatory motifs between CAC1 and CAC2, potentially governing co-expression .

Table 1: CAC2 Antibody Characteristics

PropertyDetail
Target SpeciesArabidopsis thaliana
ImmunogenGlutathione S-transferase-CAC2 fusion protein
ApplicationsWestern blot, enzymatic inhibition assays
Molecular Weight Detection51 kDa (native protein); 537 amino acids (precursor with transit peptide)
Regulatory RolepH-dependent activity modulation in chloroplasts

Table 2: CAC2 Expression Across Tissues

TissueExpression LevelFunctional Context
SeedsHighOil deposition
FlowersHighMembrane lipid synthesis
Mature LeavesModerateBaseline fatty acid production
RootsLowLimited metabolic demand for fatty acids

Significance in Plant Biology

  • Metabolic Regulation: CAC2-mediated ACCase activity is critical for balancing fatty acid synthesis under varying light conditions .

  • Biotechnological Potential: Insights from CAC2 studies inform genetic engineering of oilseed crops to enhance lipid yields .

Limitations and Future Directions

  • Current research is limited to model plants (A. thaliana); applicability in crops requires validation.

  • Further studies could explore CAC2’s interaction with other ACCase subunits and metabolic regulators.

Product Specs

Buffer
Preservative: 0.03% Proclin 300
Constituents: 50% Glycerol, 0.01M PBS, pH 7.4
Form
Liquid
Lead Time
Made-to-order (14-16 weeks)
Synonyms
CAC2 antibody; At5g35360 antibody; T26D22.8Biotin carboxylase antibody; chloroplastic antibody; EC 6.3.4.14 antibody; Acetyl-CoA carboxylase subunit A antibody; ACC antibody; EC 6.4.1.2 antibody
Target Names
CAC2
Uniprot No.

Target Background

Function
This protein is a component of the acetyl coenzyme A carboxylase complex. First, biotin carboxylase catalyzes the carboxylation of the carrier protein. Then, the transcarboxylase transfers the carboxyl group to form malonyl-CoA.
Database Links

KEGG: ath:AT5G35360

STRING: 3702.AT5G35360.3

UniGene: At.22848

Subcellular Location
Plastid, chloroplast.
Tissue Specificity
Accumulates in fatty acids synthesizing tissues. Mostly expressed in siliques, developing leaves, and flowers, present in roots and embryos (especially at torpedo stage), and, to a lower extent, in mature leaves.

Q&A

Generating a collection of FAQs for "CAC2 Antibody" research requires synthesizing antibody development methodologies and experimental design principles from available academic sources. Below is a structured framework based on antibody research best practices and technical considerations from multispecific antibody development literature , combined with intent-driven question design strategies from search behavior analysis .

What validation methods are critical for confirming CAC2 antibody specificity in immunohistochemistry (IHC)?

  • Methodological answer:

    • Perform blocking peptide assays by pre-incubating the antibody with excess target peptide to confirm signal loss.

    • Use genetic knockout controls (e.g., CRISPR/Cas9-modified cell lines lacking CAC2) to validate target binding .

    • Cross-validate with orthogonal techniques like Western blotting or SPR (surface plasmon resonance) to assess binding kinetics.

Validation StepPurposeAcceptance Criteria
Peptide BlockingConfirm epitope specificity≥80% signal reduction
Knockout ControlRule off-target bindingNo detectable signal
Cross-reactivity ScreenAssess family protein binding≤5% cross-reactivity

How should researchers address contradictory data between ELISA and flow cytometry results for CAC2?

  • Resolution framework:

    • Buffer optimization: Adjust detergent concentrations (e.g., Triton X-100) to expose epitopes in flow cytometry .

    • Conformational analysis: Use circular dichroism to determine if fixation alters CAC2’s tertiary structure.

    • Epitope mapping: Employ hydrogen-deuterium exchange mass spectrometry to identify antibody binding regions affected by assay conditions.

What strategies improve CAC2 antibody performance in multiplexed spatial proteomics workflows?

  • Technical recommendations:

    • Optimize antibody clonality: Use rabbit monoclonal antibodies (e.g., clone RB-9214-P0) for higher affinity (KD ≤ 1 nM) .

    • Implement signal amplification systems: Tyramide-based amplification for low-abundance targets.

    • Validate with reference datasets: Compare results against single-cell RNA sequencing profiles of CAC2-expressing tissues.

ParameterRequirementTool/Resource
AffinityKD ≤ 1 nMBioLayer Interferometry
Multiplex CompatibilityNo cross-talk with ≥5-plex panelsCODEX® validation
Batch ConsistencyCV ≤ 15% across lotsISO 13485 standards

How can researchers resolve discrepancies in CAC2 subcellular localization across published studies?

  • Analytical approach:

    • Contextual metadata analysis: Compare cell lines/tissue sources used in conflicting studies (e.g., neoplastic vs. normal samples).

    • Post-translational modification screening: Test for phosphorylation-dependent epitope masking using λ-phosphatase treatment.

    • Single-molecule localization microscopy: Resolve ≤40 nm localization precision using dSTORM or PALM techniques .

Methodological Guidance Table

Research StageKey ChallengeRecommended ProtocolValidation Metrics
Target ValidationOff-target bindingCRISPR knockout + MS/MS proteomics≥10-fold signal reduction
Assay DevelopmentEpitope accessibilityAntigen retrieval optimization (pH 9.0 citrate buffer)CV ≤ 20% across runs
Data InterpretationContext-dependent variabilityIntegrated omics correlation analysisR² ≥ 0.7 vs. transcriptomics

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.